The Bottom Line

DRESS syndrome is a unique severe drug reaction where the immune system's response to a medication triggers reactivation of dormant herpes family viruses (HHV-6, CMV, EBV) in your body. This drug-plus-virus combination drives an intense immune reaction affecting skin, lymph nodes, blood counts, and internal organs — particularly the liver. DRESS appears 2-8 weeks after starting certain medications and requires a prolonged, careful steroid taper because rapid withdrawal causes relapse.

Understanding DRESS and Viral Reactivation

What makes DRESS syndrome scientifically unique among drug reactions is the role of viral reactivation. In 40-60% of confirmed DRESS cases, herpes family viruses — particularly HHV-6 (human herpesvirus 6), but also CMV, EBV, and HHV-7 — reactivate during the drug reaction. These viruses lie dormant in most people's bodies from childhood infections, kept in check by normal immune surveillance.

The current understanding of DRESS pathogenesis involves a multi-step process: (1) the drug triggers an initial immune hypersensitivity response, (2) this immune activation disrupts the normal immune surveillance that keeps herpes viruses dormant, (3) the dormant viruses reactivate, (4) the immune system mounts a response against both the drug AND the reactivated virus, creating an amplified, sustained inflammatory cascade that damages internal organs.

This viral reactivation component explains several unique features of DRESS: its prolonged course (weeks to months, longer than other drug reactions), its tendency to flare during steroid taper (the virus is still active), and the development of delayed autoimmune complications (thyroid disease months later).

How DRESS Differs from Other Drug Reactions

vs. Simple drug rash: Simple drug eruptions cause only a skin rash — no fever, no organ involvement, no blood count changes. They resolve quickly after drug withdrawal. DRESS involves systemic illness with organ damage.

vs. Stevens-Johnson Syndrome/TEN: SJS/TEN causes skin necrosis (skin death and peeling). DRESS causes a morbilliform rash with facial edema but NOT skin necrosis. SJS/TEN appears at 1-3 weeks; DRESS at 2-8 weeks. SJS/TEN's danger is skin loss; DRESS's danger is organ damage (liver, heart, kidneys).

vs. Serum sickness-like reaction: Both cause rash and fever, but serum sickness involves joint pain prominently and lacks the eosinophilia, organ damage, and viral reactivation of DRESS.

The Course of DRESS — What to Expect

Week 1-2 of illness: Rash spreads, fever persists, facial edema develops, lymph nodes enlarge. Blood tests show rising eosinophils and atypical lymphocytes. Liver enzymes begin to rise. The causative drug is stopped and hospitalization begins.

Weeks 2-4: With systemic corticosteroids, the rash and fever typically begin to improve. Organ function is monitored closely. Viral reactivation may be detected on blood testing (HHV-6 PCR). The rash may evolve — areas may become more purple, others may start to peel and become dry.

Weeks 4-12 (steroid taper): This is the highest-risk period for relapse. Corticosteroids must be tapered very slowly — typically over 6-12 weeks. Rapid taper frequently causes DRESS to flare back (rash returns, fever recurs, organ damage worsens). Your doctor will check blood work at each taper step.

Months 3-12 (monitoring phase): Even after the acute DRESS resolves, delayed autoimmune complications can appear — most commonly autoimmune thyroiditis (Hashimoto's or Graves' disease, affecting 5-15% of patients). Thyroid function monitoring (TSH) is recommended every 3 months for at least 12 months.

Treatment Approach

Immediate: Stop the causative drug. Admit to hospital. Baseline organ function tests (liver, kidney, cardiac enzymes, CBC with differential).

Corticosteroids (mainstay): Systemic prednisone 0.5-2 mg/kg/day depending on severity. Taper over 6-12 weeks minimum — this extended taper is critical and unique to DRESS (other drug reactions don't require such slow tapering).

For steroid-refractory cases: Cyclosporine, IVIG, mycophenolate mofetil, or ganciclovir (if active HHV-6 reactivation is documented).

Supportive care: Emollients for skin, antipyretics for fever, nutritional support, and gentle skin care as the rash evolves through its various phases (erythematous → edematous → desquamating → resolving).

When to See a Dermatologist

DRESS is managed in the hospital during the acute phase. After discharge, follow up with both a dermatologist and an allergist/immunologist for permanent documentation of the drug allergy, identification of cross-reactive drugs to avoid, long-term monitoring for autoimmune thyroiditis, and counseling about genetic testing for family members if applicable (e.g., HLA-B*5801 testing for allopurinol-related DRESS).

Frequently Asked Questions

Why does DRESS relapse when steroids are tapered?

DRESS is sustained by both the drug hypersensitivity response AND ongoing viral reactivation. Even after the drug is stopped, the reactivated viruses (HHV-6, CMV) continue to stimulate the immune system. When corticosteroids (which suppress this immune activation) are reduced too quickly, the ongoing viral stimulation drives a relapse. This is why DRESS requires an exceptionally slow steroid taper (6-12 weeks) compared to other drug reactions.

Can I develop DRESS from a medication I've taken before without problems?

DRESS typically occurs with the first exposure to a medication (or the first prolonged course). However, prior tolerance does not guarantee future safety — immune sensitization can develop over time. The 2-8 week latency represents the time needed for the immune system to develop the hypersensitivity response. If you restart a medication after a gap, vigilance during the first 2-8 weeks is warranted.

Will I need to avoid all medications after DRESS?

No — you only need to avoid the specific drug that caused your DRESS and chemically related drugs. For example, if carbamazepine caused your DRESS, you should also avoid phenytoin and phenobarbital (aromatic anticonvulsants share cross-reactivity). Your allergist can advise specifically on which drugs to avoid and which are safe. Unrelated medications are generally not a concern.

Is the viral reactivation in DRESS contagious?

The viral reactivation (HHV-6, CMV, EBV) in DRESS is a reactivation of viruses already dormant in the patient's own body — it is NOT a new infection acquired from someone else, and you cannot spread DRESS to others. Most adults already carry these dormant viruses from childhood exposure. The DRESS drug reaction simply disrupts the immune control that normally keeps them dormant.

References

  1. Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): herpesviruses and antiviral and antidrug immune responses. Allergol Int. 2006;55(1):1-8.
  2. Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS). Br J Dermatol. 2013;169(5):1071-1080.
  3. Descamps V, Ranger-Rogez S. DRESS syndrome. Joint Bone Spine. 2014;81(1):15-21.
  4. Kano Y, Tohyama M, Aihara M, et al. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Contact Dermatitis. 2015;73(3):180-183.

Trusted Resources

DRESS requires prolonged medical management with careful steroid tapering. Follow-up monitoring for thyroid disease is essential for at least 12 months after the episode.